Moxian, Inc. (MOXC) Poised to Experience a Dramatic

New Post Public Reply Private Reply Replies (0) Message Board
MissionIR
Moxian, Inc. (MOXC) Poised to Experience a Dramatic Increase in Revenue, According to Crystal Equity Research Report

Moxian, Inc. (OTCQB: MOXC) is currently targeting China’s expansive online-to-offline (O2O) marketplace with its innovative Moxian+ platform, which is specially designed to connect businesses with consumers. This strategy could pay off for the company moving forward, according to independent capital markets research firm Crystal Equity Research. Earlier today, Moxian announced that it was the subject of a thorough report conducted by the New York-based research firm outlining the company’s tremendous prospects for future growth based on its current expansion strategy.

“In our view, Moxian is entering the market at a particularly good time,” the Crystal Equity Research report noted. “Moxian perfected and tested its O2O platform in Asian markets and is targeting the largest metropolitan areas in China. The company has earned modest revenue during the development and testing phase and appears poised to experience a dramatic increase in revenue from merchant subscriptions as the company opens sales offices in Beijing, Shanghai and Guangzhou in 2016.”

The foundation for this growth has already been placed. Last week, Moxian announced the formation of a new corporate subsidiary located in the Dongcheng district of Beijing. Through this subsidiary, the company plans to facilitate corporate growth by targeting the roughly 20 million individuals residing in the capital city of the People’s Republic of China (PRC). Following the announcement of this new subsidiary, Moxian CEO Tan Meng Dong James stated that the Beijing office represents a “qualitative leap” for Moxian in its quest to capitalize on the growing social media presence of the PRC.

In the months to come, Moxian’s ability to attract merchants to its platform will play a key role in the company’s efforts to promote financial growth, but Crystal Equity Research’s report outlines favorable economic conditions in the company’s newest market. In particular, the high penetration of smartphones and advanced cellular networks throughout China have helped O2O strategies take root, with sales related to this type of platform following an upward trajectory of roughly 25 percent per year.

The research report goes on to outline how Moxian’s current business strategies position the company for considerable market opportunity in China’s O2O sector. Spearheaded by the leadership of an experienced management team, Moxian is expected to leverage merchant fees as a significant source of recurring revenue before implementing other revenue streams – including the sale of advertising on the Moxian+ platform – to maximize the financial impact of its forecast market growth.

To view the report in its entirety, visit http://moxc.missionir.com/cereport/

For more information, visit the company’s website at http://ir.moxian.com/html-en/

Please read full disclaimers at http://disclaimer.missionir.com

Abits Group Inc. (ABTS) Stock Research Links

ABTS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 13

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 16

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 7

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 9

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 7

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 17

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 11

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 11

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 13

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 10

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading

Top 5 Most Recently Viewed Articles

Adagene Provides Insights on Phase 2 Clinical Trial Plans

Updated Category News Views 137

Adagene's Clinical Development Plan for Muzastotug Adagene Inc. (NASDAQ: ADAG), a forward-thinking company dedicated to innovating antibody-based therapies, has some exciting news to share regarding its ongoing clinical efforts. After a constructive Type B meeting with the FDA, Adagene is gearing up to move forward with its clinical development plan for muzastotug...

Continue Reading
ProVen VCT plc Shares: Total Voting Rights Announcement

Updated Category News Views 131

ProVen VCT plc Shares Summary ProVen VCT plc Total Voting Rights Announcement Under the Disclosure and Transparency Rule 5.6.1, ProVen VCT plc has disclosed important information regarding its share capital and voting rights, effective as of the end of May 2025. Details of Shares and Voting Rights As of May 31, 2025, ProVen VCT plc has outlined the following details...

Continue Reading
Celebrate Your Pets at the Tractor Supply Event This Year

Updated Category News Views 648

Tractor Supply Company Kicks Off Pet Appreciation Days Tractor Supply Company (NASDAQ: TSCO), known as the leading rural lifestyle retailer in the United States, is eager to announce the commencement of its annual Pet Appreciation Days. This event celebrates the bond between pets and their owners and provides an opportunity to enjoy exclusive deals on various pet-related...

Continue Reading
Growth Projections in the Global Acoustic Ceiling Tiles Market

Updated Category News Views 144

Overview of Acoustic Ceiling Tiles Market Custom Market Insights has recently released a comprehensive report on the global Acoustic Ceiling Tiles market. This report highlights the burgeoning demand for acoustic ceiling tiles and predicts a market worth approximately USD 11.53 billion by 2033, growing at a striking compound annual growth rate (CAGR) of 5.21% from 2024 to...

Continue Reading
Legal Investigation for Long-Term Shareholders of Major Companies

Updated Category News Views 150

Investigation of Amylyx Pharmaceuticals, Inc. Grabar Law Office is actively looking into claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX). Recent developments indicate that allegations of securities fraud in a class action have persisted against the company, successfully overcoming a motion to dismiss. What You Need to Know If you acquired...

Continue Reading